How to Be Awesome at Biostatistics and Literature Evaluation - Part II

This post explores the more applied concepts such as odds, risk, hazards, and correlation. These concepts are the heart of inferential statistics because they represent different ways of comparing one thing to another

How to Transition from a Student to a Pharmacist

Hello tl;dr friends. In addition to creating lovingly hand-crafted pharmacy knowledge bombs for your reading enjoyment, I also occasionally write for Pharmacy Times. I don't post every article that I write for Pharmacy Times here on tl;dr pharmacy...

Pharmacy School, Practice, Professional, ResidencyBrandon DysonMarch 2, 2017pharmacy student, pharmacist, pharmacy resident, residency, pharmacy residency, pharmacy times

New FDA Approval: Parsabiv

Drug

Etelcalcitide [Parsabiv]

Indication

The treatment of secondary hyperparathyroidism in adults on dialysis.

Clinical, FDA Approval, Pharmacy School, PracticeBrandon DysonFebruary 13, 2017hyperparathyroidism, PTH, parathyroid gland, etelcalcitide, Parsabiv, secondary hyperparathyroidism, calcimimetic, phosphate binder, osteoclast, bone resorption, calcium metabolism, sensipar, cinacalcet

How to Be Awesome at Biostatistics and Literature Evaluation - Part I

As with all things tl;dr pharmacy, this post will (ironically) be stupendously long. But it will serve as your one stop shop for all things biostats and clinical literature related.

Clinical, Pharmacy School, PracticeBrandon DysonFebruary 6, 2017biostats, biostatistics, literature evaluation, p-value, clinical significance, type i error, type II error, null hypothesis, alternative hypothesis, confidence interval, standard deviation, mean, median, mode, normal distribution

New FDA Approval: Vemlidy

Drug

Tenofovir alafenamide [Vemlidy]

Indication

The treatment of adults with chronic hepatitis B virus (HBV) with compensated liver disease

Clinical, FDA Approval, Pharmacy School, PracticeBrandon DysonJanuary 12, 2017Vemlidy, Tenofovir Alafenamide, tenofovir, HBV, Hepatitis B, HIV drugs cheat sheet, Viread

How to Stand Out as a Residency Applicant: An Insider's Guide

This post is sort of a "round up" of Residency Directors, Pharmacy Directors, and other influencers in the pharmacy residency sphere. In short, these are the people who interview you when you apply for residency.

I asked each of them one question:

"How can a pharmacy student make their residency application stand out?"

Practice, Professional, ResidencyBrandon DysonJanuary 2, 2017pharmacy residency, pharmacy resident, how to stand out as a pharmacy resident, how to make your residency application stand out, an insiders guide to pharmacy residency, how to make a stand out residency application, Residency, pharmacy residency interviews

New FDA Approval: Zinplava

Drug

Bezlotoxumab [Zinplava]

Indication

To reduce the recurrence of Clostridium difficile infection (CDI) in patients 18 years old and over.

FDA Approval, Clinical, Pharmacy School, PracticeBrandon DysonDecember 4, 2016zinplava place in therapy, zinplava, bezlotoxumab, bezlotoxumab place in therapy, zinplava adverse effects, bezlotoxumab adverse effects

Heart Failure Part 3: Pharmacotherapy

Ok, so now onto pharmacotherapy - updated for the 2022 Guidelines!

Last time we talked about signs and symptoms and discussed the Frank-Starling curve. We are going to talk about the agents used in HF and how they affect this curve.

Clinical, Residency, PracticeBrandon DysonNovember 12, 2016heart failure, systolic heart failure, diastolic heart failure, HFpEF, HFrEF, HF, CHF, Clinical Pearls, congestive heart failure, cardiovascular, digoxin

Pain Management: The tl;dr Pharmacy Guide

Opioid abuse comes in many forms; and it's not just the stereotypical junkie that's doctor shopping and trying to refill their Norco 2 weeks early "because the cops stole them." Opioid abuse can also show up in more insidious ways.....

Clinical, Pharmacy School, PracticeSamuel OhOctober 13, 2016Clinical Pearls, Pain, Pharmacotherapy, COX-2, NSAIDs, Opioids, Tramadol, Pain Management, Neuropathy, Nociception, opioid conversions, opioid clinical pearls, opioid cheat sheet, pain management, pain management cheat sheet

New FDA Approval: Amjevita

Drug

Adalimumab-atto [Amjevita]

Indication

Amjevita is a biosimilar to adalimumab [Humira], so it has the same indications. It's used in inflammatory conditions mediated by the immune system

FDA Approval, Clinical, Pharmacy School, PracticeBrandon DysonOctober 10, 2016Amjevita, adalimumab, biosimilar, amjevita place in therapy, adalimumab place in therapy

HIV Boot Camp: Entry Inhibitors & Attachment Inhibitors

Well, we're coming full circle here. Our epic series on HIV is nearing its coda. We've only got one "class" of HIV meds left to talk about.

The Entry Inhibitors.

Clinical, Pharmacy School, Practice, ResidencyBrandon DysonSeptember 25, 2016hiv boot camp, entry inhibitor mechanism of action, hiv entry inhibitors, hiv cheat sheet, hiv clinical pearls, maraviroc dosing, enfuvirtide administration, enfuvirtide dosing, maraviroc drug interactions, hiv therapy cheat sheet, entry inhibitor clinical pearls, fusion inhibitor

The Complete (but Practical) Guide to Aminoglycosides

Before we get too far, let’s clarify what drugs fall in the aminoglycoside class. That way we’re all on the same page. When we talk about aminoglycosides, we’re referring to gentamicin, tobramycin, and amikacin.